Bracebridge Capital LLC’s BioPlus Acquisition Corp. Unit BIOSU Stock Holding History

Bracebridge Capital LLC’s Portfolio BIOSU Stock Details BIOSU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-50,000	Closed	-$524K	–	78
2023 Q1	$524K	Hold	50,000	–	–	0.14%	38
2022 Q4	$510K	Hold	50,000	–	–	0.05%	62
2022 Q3	$503K	Hold	50,000	–	–	0.09%	81
2022 Q2	$503K	Hold	50,000	–	–	0.08%	81
2022 Q1	$499K	Hold	50,000	–	–	0.04%	86
2021 Q4	$500K	Buy	+50,000	New	+$501K	0.03%	92

Other funds holding BIOSU

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Bracebridge Capital LLC's BIOSU Position: Q2 2023 in Review

Bracebridge Capital LLC sold out of BioPlus Acquisition Corp. Unit (BIOSU) in Q2 2023, closing a stake of 50,000 shares — an estimated $524K sold.

Bracebridge Capital LLC first reported a position in BIOSU in Q4 2021 and held it in 6 quarters. The position peaked at $524K in Q1 2023. 2 funds tracked by Wall St. Rank hold BIOSU as of Q2 2023.

Bracebridge Capital LLC reported no remaining BioPlus Acquisition Corp. Unit position as of Q2 2023 after selling out during the quarter.
Bracebridge Capital LLC sold 50,000 BioPlus Acquisition Corp. Unit shares in Q2 2023, an estimated $524K.
Bracebridge Capital LLC first reported a position in BioPlus Acquisition Corp. Unit in Q4 2021 and held it in 6 quarters.
Bracebridge Capital LLC's BioPlus Acquisition Corp. Unit position peaked at $524K in Q1 2023.
2 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Unit as of Q2 2023.

Based on Bracebridge Capital LLC's 13F filing for Q2 2023, filed 14 Aug 2023.